WOMEN 'S HEALTH AND MENOPAUSE : - National Heart, Lung ...

18 Pyörälä K, De Backer G, Graham I, Poole-Wilson P,
Wood D. Prevention of coronary heart disease in
clinical practice. Recommendations of the Task
Force of the European Society of Cardiology,
European Atherosclerosis Society and European
Society of Hypertension. Eur Heart J
1994;15(10):1300–31.
19 MacMahon S, Peto R, Cutler J, et al. Blood pressure,
stroke, and coronary heart disease. Part 1,
Prolonged differences in blood pressure: prospective
observational studies corrected for the regression
dilution bias. Lancet 1990;335(8692):765–74.
20 Saltzberg S, Stroh JA, Frishman WH. Isolated systolic
hypertension in the elderly: pathophysiology and
treatment (review). Med Clin North Am
1988;72(2):523–47.
21 SHEP Cooperative Research Group. Prevention of
stroke by antihypertensive drug treatment in older
persons with isolated systolic hypertension. Final
results of the Systolic Hypertension in the Elderly
Program (SHEP). JAMA 1991;265(24):3255–64.
22 Kostis JB, Davis BR, Cutler J, et al. Prevention of
heart failure by antihypertensive drug treatment in
older persons with isolated systolic hypertension.
SHEP Cooperative Research Group. JAMA
1997;278(3):212–6.
23 D’Agostino RB, Belanger AJ, Kannel WB,
Cruickshank JM. Relation of low diastolic blood
pressure to coronary heart disease death in presence
of myocardial infarction: the Framingham
Study. BMJ 1991;303(6799):385–9.
24 Sowers JR. Diabetes mellitus and cardiovascular disease
in women (review). Arch Intern Med
1998;158(6):617–21.
25 Haffner SM, Lehto S, Ronnemaa T, Pyorala K,
Laakso M. Mortality from coronary heart disease in
subjects with type 2 diabetes and in nondiabetic
subjects with and without prior myocardial infarction.
N Engl J Med 1998;339(4):229–34.
26 Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein
SL. Why is diabetes mellitus a stronger risk factor
for fatal ischemic heart disease in women than in
men? The Rancho Bernardo Study [published erratum
appears in JAMA 1991;265(24):3249]. JAMA
1991;265(5):627–31.
27 Barrett-Connor E, Wingard DL. Sex differential in
ischemic heart disease mortality in diabetics: a
prospective population-based study. Am J
Epidemiol 1983;118(4):489–96.
28 Kaseta JR, Skafar DF, Ram JL, Jacober SJ, Sowers
JR. Cardiovascular disease in the diabetic woman
(review). J Clin Endocrinol Metab
1999;84(6):1835–8.
29 Sacks FM, Pfeffer MA, Moye LA, et al. The effect of
pravastatin on coronary events after myocardial
infarction in patients with average cholesterol levels.
Cholesterol and Recurrent Events Trial
Investigators. N Engl J Med 1996;335:1001–9.
30 Downs JR, Clearfield M, Weis S, et al. Primary prevention
of acute coronary events with lovastatin in
men and women with average cholesterol levels:
results of AFCAPS/TexCAPS. Air Force/Texas
Coronary Atherosclerosis Prevention Study. JAMA
1998;279(20):1615–22.
31 Prevention of cardiovascular events and death with
pravastatin in patients with coronary heart disease
and a broad range of initial cholesterol levels. The
Long-Term Intervention with Pravastatin in
Ischaemic Disease (LIPID) Study Group. N Engl J
Med 1998;339(19):1349–57.
32 Must A, Spadano J, Coakley EH, Field AE, Colditz G,
Dietz WH. The disease burden associated with
overweight and obesity. JAMA
1999;282(16):1523–9.
33 Martínez-González MA, Martínez JA, Hu FB, Gibney
MJ, Kearney J. Physical inactivity, sedentary
lifestyle and obesity in the European Union. Int J
Obes Relat Metab Disord 1999;23(11):1192–201.
34 Samaras K, Kelly PJ, Chiano MN, Spector TD,
Campbell LV. Genetic and environmental influences
on total-body and central abdominal fat: the
effect of physical activity in female twins. Ann
Intern Med 1999;130(11):873–82.
35 Jakicic JM, Winters C, Lang W, Wing RR. Effects of
intermittent exercise and use of home exercise
equipment on adherence, weight loss, and fitness in
overweight women: a randomized trial. JAMA
1999;282(16):1554–60.
169